Rajeev Venkayya MD
rvenkayya
It was good to discuss this with @HelenBranswell. Patents aren't a constraint to access. These things are:Lack of capacity at originators to support more tech transfers;Partners w/proven global vaccine manufacturing
Read more
More exciting vaccine news from Oxford/AstraZeneca. These would normally be considered very good results. Would be cautious about early comparisons to mRNA, given that we haven’t seen full datasets and
Read more
High-risk settings like prisons and meat packing plants are perfect targets for wastewater surveillance. Virus detection triggers universal testing before the outbreak takes off, protecting people and helping plants to
Read more
This is a thread on the use of antibody tests (serology) to gauge individual risk for COVID-19 infection. It's triggered by the recent @WHO guidance and the push for "immunity
Read more